Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
541 - Can you please advise if CADTH Common Drug Review publications can be used as evidence for efficacy, pharmacoeconomic or recommendation claims?
-
No. These reviews have important uses (e.g. explaining recommendations for funding decisions) but they are not designed or intended to support product claims in drug advertising. Please refer to the PAAB Tips document Marketing Benefit Claims http://www.paab.ca/Marketing_Benefit_Claims_-_June_22.pdf for the evidentiary requirements relating to common types of claims.
